相关实验视频
Updated: Jan 17, 2026

08:38
Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
Published on: September 1, 2011
75.5K
布雷克斯皮普拉:在阿尔茨海默氏病中管理激动的开创性药物
Ayesha Shaukat1, Rumaisa Riaz1, Nawal Khaliq1
1Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Journal of Alzheimer's disease reports
|September 19, 2025
概括
布雷克西普拉是第一个FDA批准的治疗阿尔茨海默病相关的激动症,通过调节血清素-多巴胺活性,有效减少症状. 建议逐渐剂量,并注明潜在的副作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 老年病的医生 老年病的医生
背景情况:
- 阿尔茨海默病带来了重大的认知和行为挑战,焦虑是其中一个突出的症状.
- 目前对阿尔茨海默氏症相关动荡的治疗方法有限,造成了未满足的医疗需求.
研究的目的:
- 评估布雷克斯皮普拉 (brexpiprazole) 在治疗与阿尔茨海默病相关的动症的疗效和安全性.
- 建立brexpiprazole作为一种新的治疗选择,用于管理阿尔茨海默病患者的行为障碍.
主要方法:
- 临床试验评估了使用科恩-曼斯菲尔德激发库存 (CMAI) 尺度对布雷克西普拉对激发的影响.
- 该研究涉及逐渐增加布雷克斯皮普拉的剂量,以优化治疗效果并最大限度地减少不良事件.
主要成果:
- 布雷克西普拉在阿尔茨海默病患者中显著减少了兴奋症状,CMAI得分的改善证明了这一点.
- 药物的机制包括调节血清素和多巴胺通路,有助于其疗效.
结论:
- 布雷克西普拉作为第一个专门用于阿尔茨海默病相关激动症的FDA批准的药物,代表了重大进展.
- 虽然有效,但建议仔细监测潜在的副作用,如鼻炎,尿路感染,头,昏昏欲睡,头痛和失眠.
相关概念视频
Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
Antidepressant Drugs: MAOIs and Other Agents
828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
Psychosis: Goals of Pharmacotherapy
476
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
476
Parkinson's Disease: Treatment
987
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
987
Psychosis and Antipsychotic Drugs: Overview
817
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
817
Anxiolytic Drugs: Benzodiazepines and Buspirone
2.4K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.4K

